DIRECTOR :
DASHRATHBHAI KALIDAS PATEL
As On :
Friday, 22 November 2024
Total Page Views : 11 Name | DASHRATHBHAI KALIDAS PATEL |
Total Companies | 11 |
First Appointment Date | Tuesday, 01 April 2003 |
Last Resigned Date | Wednesday, 29 December 2010 |
Social Links | |
DASHRATHBHAI KALIDAS PATEL was appointed on Tuesday, 01 April 2003 with ACME SKIN CARE PRIVATE LIMITED - AHMEDABAD - Total Tenure of 21 Year(s), 7 month(s), 21 day(s), and also appointed on Monday, 02 April 2007 with ACME REMEDIES PRIVATE LIMITED - AHMEDABAD - Total Tenure of 17 Year(s), 7 month(s), 20 day(s), and also appointed on Wednesday, 11 April 2007 with ACME HEALTHCARE PRIVATE LIMITED. - AHMEDABAD - Total Tenure of 17 Year(s), 7 month(s), 11 day(s), and also appointed on Wednesday, 29 December 2010 with GERMAN REMEDIES PHARMACEUTICALS PRIVATE LIMITED - AHMEDABAD and resigned on Wednesday, 29 December 2010. - Total Tenure of 0 Year(s), 0 month(s), 0 day(s), and also appointed on Friday, 24 February 2012 with SHANKUS ACME PHARMA PRIVATE LIMITED - AHMEDABAD - Total Tenure of 12 Year(s), 8 month(s), 27 day(s), and also appointed on Monday, 05 May 2014 with ACME DIET CARE PRIVATE LIMITED - AHMEDABAD - Total Tenure of 10 Year(s), 6 month(s), 17 day(s), and also appointed on Tuesday, 12 May 2015 with ACME LIFETECH LLP - AHMEDABAD - Total Tenure of 9 Year(s), 6 month(s), 10 day(s), and also appointed on Thursday, 03 May 2018 with ACMEDIX PHARMA LLP - AHMEDABAD - Total Tenure of 6 Year(s), 6 month(s), 19 day(s), and also appointed on Friday, 17 September 2021 with ACMEGEN LLP - AHMEDABAD - Total Tenure of 3 Year(s), 2 month(s), 5 day(s), and also appointed on Tuesday, 05 October 2021 with ACME PHARMACEUTICALS & HEALTH LLP - AHMEDABAD - Total Tenure of 3 Year(s), 1 month(s), 17 day(s), and also appointed on Friday, 10 March 2023 with NEOVANT THERAPEUTICS PRIVATE LIMITED - AHMEDABAD - Total Tenure of 1 Year(s), 8 month(s), 12 day(s)
Rank | Logo | CIN | Company Name | City | Appointed Date | Resign Date | Date of Incorporation | Status |
1056815 | | U24231GJ2002PTC040375 | ACME SKIN CARE PRIVATE LIMITED | AHMEDABAD | Tuesday, 01 April 2003 | | Monday, 21 January 2002 | |
1520096 | | U24233GJ2007PTC050434 | ACME REMEDIES PRIVATE LIMITED | AHMEDABAD | Monday, 02 April 2007 | | Monday, 02 April 2007 | |
1521899 | | U24239GJ2007PTC050502 | ACME HEALTHCARE PRIVATE LIMITED. | AHMEDABAD | Wednesday, 11 April 2007 | | Wednesday, 11 April 2007 | |
8032 | | U24230GJ2010PTC063425 | GERMAN REMEDIES PHARMACEUTICALS PRIVATE LIMITED | AHMEDABAD | Wednesday, 29 December 2010 | Wednesday, 29 December 2010 | Wednesday, 29 December 2010 | |
1482203 | | U24230GJ2012PTC069152 | SHANKUS ACME PHARMA PRIVATE LIMITED | AHMEDABAD | Friday, 24 February 2012 | | Friday, 24 February 2012 | |
74318 | | U24231GJ2002PTC040372 | ACME DIET CARE PRIVATE LIMITED | AHMEDABAD | Monday, 05 May 2014 | | Friday, 18 January 2002 | |
1507962 | | AAD-9246 | ACME LIFETECH LLP | AHMEDABAD | Tuesday, 12 May 2015 | | Tuesday, 12 May 2015 | |
1717521 | | AAM-5488 | ACMEDIX PHARMA LLP | AHMEDABAD | Thursday, 03 May 2018 | | Thursday, 03 May 2018 | |
3247044 | | AAY-6489 | ACMEGEN LLP | AHMEDABAD | Friday, 17 September 2021 | | Friday, 17 September 2021 | |
3252835 | | AAY-8909 | ACME PHARMACEUTICALS & HEALTH LLP | AHMEDABAD | Tuesday, 05 October 2021 | | Tuesday, 05 October 2021 | |
2700398 | | U21002GJ2023PTC138826 | NEOVANT THERAPEUTICS PRIVATE LIMITED | AHMEDABAD | Friday, 10 March 2023 | | Thursday, 23 February 2023 | |
Suit Filed accounts of Rs. 25 Lacs and above Total Suit Filed : 0
# | Category | Bank / FI | Branch | Outstanding Amount In Lacs | Asset Classification | Date Of Classification | Suit |
Report Director Information Discrepancy
The information shown on this page was last updated onFriday, 22 November 2024
Due to frequent changes in Director Information, it is possible that some details you see may be out-of-date. If you feel the information is not up-to-date, you may request to get this page auto-updated now.
Request For Update If you still notice any discrepancy, please help by reporting it to us.
We appreciate your help!
Report Discrepancy